Risk of Alopecia Areata After COVID-19
This cohort study examines the incidence, prevalence, and risk of alopecia areata after COVID-19. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Error in Figure 2
In the Consensus Statement titled “International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis,” there was an error in panel B of Figure 2. The black vertical dashed line was meant to mark 30%, not 25%. The article has been corrected online. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Segmental Skin Induration in a Boy
An 11-year-old boy presented with progressive unilateral skin hardening on his right thigh and buttock for 7 years. What is your diagnosis? (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma
This case-control study examines genetic risk factors associated with early-onset Merkel cell carcinoma. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Lived Experience of Acne and Acne Treatment in Transgender Patients
This mixed-methods study examines the lived experiences of acne and acne treatment in transgender and gender-diverse individuals. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Clinical Characteristics of Erythema Nodosum and Associations With Chronicity and Recurrence
This cohort study characterizes the presentation, causes, treatment, and disease course of erythema nodosum, as well as identifies associations with chronicity and recurrence. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Papular Mucinosis
This case report describes erythematous patches on the face that involved the nasolabial folds, as well as numerous skin-colored homogenous waxy papules on the arms, neck, and trunk. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Erythroderma in a Patient With Thymoma-Associated Myasthenia Gravis
A woman in her 30s with myasthenia gravis diagnosed at age 27 years presented to the emergency department with severe erythroderma over the past 2 months. What is your diagnosis? (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
JAMA Dermatology
Mission Statement: JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of inn ovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. The journal also features research and opinion examining e thical, m...
Source: JAMA Dermatology - January 1, 2024 Category: Dermatology Source Type: research
Errors in Figures 3 and 4
This article has been corrected. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 1, 2024 Category: Dermatology Source Type: research
Melanoma Incidence Rates Among Non-Hispanic American Indian/Alaska Native Individuals, 1999-2019
This cross-sectional study examines invasive cutaneous melanoma incidence rates and trends over time among non-Hispanic American Indian/Alaska Native people. (Source: JAMA Dermatology)
Source: JAMA Dermatology - December 27, 2023 Category: Dermatology Source Type: research
Amending the Pain Scale Used for Postoperative Pain Studies —Reply
In Reply We appreciate the thoughtful comments by Rubin and Lo and agree that more research evaluating the use of opioids in dermatology is warranted. Rubin and Lo correctly highlight that there are wide-ranging preferences between patients. While most patients preferred to use over-the-counter (OTC) medications alone when the risk of addiction was higher than 0% in our study, there was a subset of patients who preferred to use opioids in addition to OTC medications for pain management when there was less potential for addiction. (Source: JAMA Dermatology)
Source: JAMA Dermatology - December 27, 2023 Category: Dermatology Source Type: research
Amending the Pain Scale Used for Postoperative Pain Studies
To the Editor We read with great interest the article by Nugent et al and would like to contribute additional insights to further the discussion on the use of opioids following Mohs micrographic surgery (MMS). In the study, Nugent et al discovered that when the theoretical risk of opioid addiction is assumed to be 0%, the median risk equivalence was found to be 6.5 on the Mankoski pain scale. However, when the theoretical risk rose above 0%, no median risk equivalence was observed. We would like to raise a question regarding the inclusion of an 8 on the Mankoski pain scale in the survey design, considering that most patien...
Source: JAMA Dermatology - December 27, 2023 Category: Dermatology Source Type: research
High Melanoma Rates in the American Indian and Alaska Native Population —a Unique Challenge
In the Navajo language, cancer is broadly described as łóód dóó nádzi híí, which translates directly as a “sore that does not heal.” Accurate determination of cancer incidence in a specified population is a critical first step toward addressing disease burden. Previous studies have shown that racial misclassification is a problem that hinder s epidemiologic research in American Indian/Alaska Native populations and underestimates American Indian/Alaska Native cancer incidence. In this issue of JAMA Dermatology, Townsend et al use a method that corrects for racial misclassification among American Indian/Alaska Na...
Source: JAMA Dermatology - December 27, 2023 Category: Dermatology Source Type: research
PF-07038124 for Atopic Dermatitis and Plaque Psoriasis
This phase 2a randomized clinical trial assesses the efficacy, safety, tolerability, and pharmacokinetics of topical PF-07038124 in patients with mild to moderate atopic dermatitis or plaque psoriasis. (Source: JAMA Dermatology)
Source: JAMA Dermatology - December 20, 2023 Category: Dermatology Source Type: research
